Brief intervention to enhance cessation of smokeless tobacco use in newly diagnosed patients with head and neck cancers: A randomized controlled trial in patient-relative dyads

Head and neck cancers are strongly linked to tobacco use, especially smokeless tobacco, which is prevalent in regions like India and Pakistan. Continued tobacco use after diagnosis worsens health outcomes.

This research explores how brief behavioral interventions can support newly diagnosed patients and their relatives in quitting smokeless tobacco, aiming to improve treatment success and survival rates.

Understanding effective behavioral strategies to promote tobacco cessation can significantly improve health outcomes for cancer patients and reduce the burden of tobacco-related diseases.

Implementing such interventions can lead to better treatment responses, lower recurrence rates, and overall improved quality of life for patients.

This research highlights the importance of targeted behavioral interventions in tobacco control, especially for high-risk groups like head and neck cancer patients. It underscores the need for public health policies that promote early cessation support.

Reducing smokeless tobacco use through effective interventions can substantially decrease the incidence and mortality of tobacco-related cancers in Pakistan and similar settings.

The findings support the development of policies that integrate behavioral counseling into cancer care protocols. Such policies can enhance cessation rates and improve patient outcomes.

Public health strategies should prioritize education and support systems for tobacco users, especially in regions with high smokeless tobacco consumption.